Dawn Parsell
2019
In 2019, Dawn Parsell earned a total compensation of $3M as Executive Vice President, Clinical Development at Tricida, a 19% decrease compared to previous year.
Compensation breakdown
| Bonus | $17,053 |
|---|---|
| Non-Equity Incentive Plan | $144,900 |
| Option Awards | $2,373,266 |
| Salary | $416,667 |
| Total | $2,951,886 |
Parsell received $2.4M in option awards, accounting for 80% of the total pay in 2019.
Parsell also received $17.1K in bonus, $144.9K in non-equity incentive plan and $416.7K in salary.
Rankings
In 2019, Dawn Parsell's compensation ranked 4,156th out of 13,971 executives tracked by ExecPay. In other words, Parsell earned more than 70.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,156 out of 13,971 | 70th |
Division Manufacturing | 1,513 out of 5,701 | 74th |
Major group Chemicals And Allied Products | 529 out of 2,200 | 76th |
Industry group Drugs | 445 out of 1,886 | 76th |
Industry Pharmaceutical Preparations | 341 out of 1,398 | 76th |
Source: SEC filing on April 29, 2020.
Parsell's colleagues
We found four more compensation records of executives who worked with Dawn Parsell at Tricida in 2019.
News
Tricida CEO Gerrit Klaerner's 2021 pay falls 47% to $4.7M
April 25, 2022
Tricida CEO Gerrit Klaerner's 2020 pay slips 13% to $8.9M
April 23, 2021
Tricida CEO Gerrit Klaerner's 2019 pay jumps 579% to $10M
April 29, 2020
Tricida Senior Vice President of Clinical Development Dawn Parsell receives $3.7M in 2018
April 18, 2019